CVR 16279099Public limited company (A/S)Fremstilling af farmaceutiske præparater (212000)BirkerødFounded 1 Jul 1992
Employees
40
CVR registry, Aug 2026
0 (0%) over 12 months
Gross profit
29.7M
DKK, annual report 2025
+10.5% on 2024
Result
+962.7K
DKK, annual report 2025
Equity
3M
DKK, annual report 2025
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about SCANPHARM A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexCHLOPETHAN A/SCVR 25732766, 90% to under 100% of capital and votes, since 19 Dec 2011
Peluli Holding ApSCVR 39267578, 10% to under 15% of capital and votes, since 22 Jan 2018
Andreas Bjørn Jensensince 28 Feb 2019
CVR 2573276690% to under 100% of capital and votessince 19 Dec 2011
CVR 3926757810% to under 15% of capital and votessince 22 Jan 2018
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 2913464210% to under 15% of capital and votes30 Jan 2018 to 1 Mar 2019
Ultimate controller
Holds 100% of capital and votes in CHLOPETHAN A/S, since 23 Feb 2026
Holding company
CVR 25732766Public limited company (A/S)
Holds 90% to under 100% of capital and votes in SCANPHARM A/S, since 19 Dec 2011
This company
SCANPHARM A/S
CVR 16279099
CVR records founders at incorporation. It does not record whether they are alive or still involved.
1 Jul 1992 to 4 Nov 2026.
1 Jul 1992 to 4 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 11,259 | 17,399 | 22,519 | 26,904 | 29,717 |
| Operating profit | -9,718 | -5,205 | -3,533 | +1,679 | +1,721 |
| Result for the year | -10,871 | -5,954 | -4,425 | +583 | +963 |
| Equity | 1,500 | 1,500 | 1,500 | 2,083 | 3,045 |
| Total assets | 28,911 | 29,659 | 31,602 | 35,068 | 39,207 |
| Employees (average) | 40 | 41 | 44 | 42 | 0 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 120% | 54.5% | 29.4% | 19.5% | 10.5% |
| EBITDA | -7,981 | -3,394 | -1,815 | 2,942 | 3,472 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | -70.9% | -19.5% | -8.1% | 10.9% | 11.7% |
| Employee growth (vækst i antal ansatte) | 0% | 2.5% | 7.3% | -4.6% | Not reportednote 1 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 14,770 | 9,573 | 12,240 | 10,741 | 12,053 |
| Gearing, NIBD / EBITDA | n.m.note 2 | n.m.note 2 | n.m.note 2 | 3.7x | 3.5x |
| ROIC (afkast af investeret kapital) | -42.6%note 3 | -29.7%note 3 | -22.2%note 3 | 9.9%note 4 | 12.3% |
| Capex (investeringer i anlægsaktiver) | 588note 5 | 1,026note 5 | 2,226note 5 | 3,827note 5 | Not reportednote 6 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 18,952 | 18,727 | 20,207 | 21,735 | 23,034 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 15 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 20 May 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 2 Jul 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 3 Jul 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 5 Jul 2022
2 registered in CVR.
P-number 1003475404Kirkevej 20, 4690 Haslev
P-number 1001071414Topstykket 12, 3460 Birkerød
